<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00930397</url>
  </required_header>
  <id_info>
    <org_study_id>CRC 07049</org_study_id>
    <nct_id>NCT00930397</nct_id>
  </id_info>
  <brief_title>Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy</brief_title>
  <acronym>PLACENTA3D</acronym>
  <official_title>The Evaluation of UTERO - Placental 3D Doppler Examination Potential Interest for Pre- Eclampsia Screening During Pregnancy. Observational Study in 100 Women at High Risk for Pre- Eclampsia and 70 Low Risk Women.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GE Medical Systems ultrasound (only technical support)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-eclampsia and intra uterine growth restriction (IUGR) represent major complications for&#xD;
      pregnant women, with a high related maternal and fetal morbidity and mortality. It is now&#xD;
      widely admitted that these pathologies, which can concern up to 7% of pregnancies, are in&#xD;
      relation with hypo-perfusion of the placenta because of an early deficient trophoblast&#xD;
      invasion and uterine vascular remodelling.Advances in ultrasound imaging now permit non&#xD;
      invasive 3D volume and Doppler signal quantification using automatic&#xD;
      acquisitions.Quantitative comparison of volumes and Doppler parameters between control&#xD;
      pregnancies and IUGR ought to confirm the theory of UTERO-placental hypo-perfusion. This&#xD;
      technique might allow an earlier prediction for IUGR. The aim of this study is to evaluate&#xD;
      the interest of 3D Doppler quantification as a new screening tool for pre eclampsia and IUGR.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred high risk women and 70 low risk women will be included. Inclusion criteria for&#xD;
      the high risk group are: personal history of pre eclampsia and/or IUGR in a previous&#xD;
      pregnancy, diabetes, auto-immune syndrome such as LUPUS, hypertension, renal insufficiency,&#xD;
      and anti-phospholipid syndrome.Patients (over 18 years old) will be included between 11 and&#xD;
      14(+6days) WG. Only singletons pregnancies will be included.3D Doppler standardized&#xD;
      acquisitions of the UTERO-placental unit will be performed at each usual ultrasound&#xD;
      examination of the pregnancy.Data will be analysed after delivery, in terms of quantified&#xD;
      Doppler values, comparing two groups: pregnancies with pre eclampsia / IUGR (group with&#xD;
      pathology) and normal pregnancies (control group).This is an observational study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of pre eclampsia and/or IUGR</measure>
    <time_frame>at the end of the pregnancy</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">146</enrollment>
  <condition>Pre-eclampsia</condition>
  <condition>Intra-uterine Growth Restriction</condition>
  <condition>Placental Insufficiency</condition>
  <condition>3D Doppler Ultrasound</condition>
  <arm_group>
    <arm_group_label>Low risk women</arm_group_label>
    <description>Women without any personal risk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High risk women</arm_group_label>
    <description>Women at high risk for pre-eclampsia with personal of pre-eclampsia and/or IUGR in a previous pregnancy, diabetes, auto-immune syndrome such as lupus, hypertension, renal insufficiency and anti-phospholipid.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        100 women high risk of pre-eclampsia and 70 women low risk women of pre-eclampsia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age eligible for study up to 18 years&#xD;
&#xD;
          -  Gestational age between 11 to 14 weeks for the first visit (first-trimester&#xD;
             pregnancy).-Singleton pregnancy&#xD;
&#xD;
          -  Consent to participate in the study&#xD;
&#xD;
          -  Patients affiliated to social security&#xD;
&#xD;
        Group 1:&#xD;
&#xD;
        -Personal History of:&#xD;
&#xD;
          -  Preeclampsia during a previous pregnancy: Blood pressure more than 140 mmHg systolic&#xD;
             and/or 90 mmHg diastolic + proteinuria&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  IUGR during a previous pregnancy (birth weight &lt; 10th centile)&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Renal insufficiency&#xD;
&#xD;
          -  Autoimmune Disease : Antiphospholipid syndrome&#xD;
&#xD;
        Group 2:Absence of all the Group 1 affiliation criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participating in the study&#xD;
&#xD;
          -  Unability to understand the study&#xD;
&#xD;
          -  Set back of patient consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier MOREL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital LARIBOISIERE Service de gynécologie- obstétrique</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <study_first_submitted>June 29, 2009</study_first_submitted>
  <study_first_submitted_qc>June 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2009</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pre-eclampsia</keyword>
  <keyword>UTERO-placental unit vascularization</keyword>
  <keyword>Hypertension, pregnancy- induced</keyword>
  <keyword>IUGR</keyword>
  <keyword>Screening</keyword>
  <keyword>3D Doppler Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Placental Insufficiency</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

